A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
暂无分享,去创建一个
M. Hayden | B. Weiner | M. Thoma | D. Laifenfeld | R. Kusko | B. Zeskind | I. Grossman | V. Knappertz | C. Ross | F. Towfic | Matthew Davis | J. Shankar | M. Davis | Mathis Thoma